Cargando…
Imlifidase for Kidney Transplantation of Highly Sensitized Patients With a Positive Crossmatch: The French Consensus Guidelines
Imlifidase recently received early access authorization for highly sensitized adult kidney transplant candidates with a positive crossmatch against an ABO-compatible deceased donor. These French consensus guidelines have been generated by an expert working group, in order to homogenize patient selec...
Autores principales: | Couzi, Lionel, Malvezzi, Paolo, Amrouche, Lucile, Anglicheau, Dany, Blancho, Gilles, Caillard, Sophie, Freist, Marine, Guidicelli, Gwenda Line, Kamar, Nassim, Lefaucheur, Carmen, Mariat, Christophe, Koenig, Alice, Noble, Johan, Thaunat, Olivier, Thierry, Antoine, Taupin, Jean-Luc, Bertrand, Dominique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10336835/ https://www.ncbi.nlm.nih.gov/pubmed/37448448 http://dx.doi.org/10.3389/ti.2023.11244 |
Ejemplares similares
-
Prime Time for HLA Desensitization: Imlifidase in the Spotlight
por: Bestard, Oriol, et al.
Publicado: (2023) -
Imlifidase Desensitization in Crossmatch-positive, Highly Sensitized Kidney Transplant Recipients: Results of an International Phase 2 Trial (Highdes)
por: Jordan, Stanley C., et al.
Publicado: (2021) -
Conversion From Intravenous In-Hospital Belatacept Injection to Subcutaneous Abatacept Injection in Kidney Transplant Recipients During the First COVID-19 Stay-at-Home Order in France
por: Bertrand, Dominique, et al.
Publicado: (2023) -
IMPact of the COVID-19 epidemic on the moRTAlity of kidney transplant recipients and candidates in a French Nationwide registry sTudy (IMPORTANT)
por: Thaunat, Olivier, et al.
Publicado: (2020) -
Management and Outcome After Early Renal Transplant Vein Thrombosis: A French Multicentre Observational Study of Real-Life Practice Over 24 Years
por: Cambou, Ludivine, et al.
Publicado: (2023)